1. Qing-dai powder promotes recovery of colitis by inhibiting inflammatory responses of colonic macrophages in dextran sulfate sodium-treated mice
- Author
-
Dong-Dong Hu, Jiao Peng, Chengyuan Lin, Xiao Jun Zhang, Zhaoxiang Bian, Ze Si Lin, Bin Du, Siu Wai Tsang, Haitao Xiao, Feng Ping Lueng, and Quan-Bin Han
- Subjects
Pharmacology ,medicine.medical_specialty ,Traditional medicine ,Lipopolysaccharide ,Dose ,business.industry ,Research ,medicine.disease ,Ulcerative colitis ,Gastroenterology ,Proinflammatory cytokine ,chemistry.chemical_compound ,Complementary and alternative medicine ,chemistry ,Sulfasalazine ,Oral administration ,Internal medicine ,medicine ,Colitis ,business ,Acute colitis ,medicine.drug - Abstract
Background Qing-dai powder (QDP), comprising Indigo naturalis (Qing-dai) and dried alum (Ku-fan), was used in Chinese medicine to treat the conditions associated with mucosal hemorrhage, such as ulcerative colitis (UC). This study aims to investigate the effects and potential mechanism of QDP on dextran sulfate sodium (DSS)-induced acute colitis in mice and to examine the regulatory effects of QDP on macrophages. Methods Seven- to eight-week-old male C57BL/6 mice were challenged with 2.0 % DSS in drinking water for 5 days and then the colitic mice were arbitrarily allocated into five groups (n = 10 for each group). QDP (0.77, 1.54 and 3.08 g/kg) and sulfasalazine (SASP) (0.20 g/kg) were orally administered for 7 days. The disease activity index was determined by scores of body weight loss, diarrhea and rectal bleeding; histological signs of damage was analyzed by H&E staining; myeloperoxidase activity was measured by colorimetric method, levels of proinflammatory cytokines were determined by ELISA; changes in macrophages in the colon were analyzed by immunohistochemistry (IHC) and flow cytometry. Lipopolysaccharide (LPS)-induced RAW264.7 cells were treated with or without QDP, then the production of TNF-α and IL-6 were measured by ELISA; and protein molecules such as COX-2, iNOS, IкB-α were determined by Western blot. Results Oral administration of QDP at dosages of 1.54 and 3.08 g/kg significantly reduced disease activity index on day 12 (P
- Published
- 2015
- Full Text
- View/download PDF